Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Cellular Adaptation I: Introduction and Atrophy01:23

Cellular Adaptation I: Introduction and Atrophy

Cells can adapt to environmental changes to maintain function and avoid injury, a process called cellular adaptation. Adapted cells exist in a reversible intermediate state with changes in size, number, phenotype, metabolism, or function. These responses help cells meet altered physiological or pathological demands; for example, enlargement of breast and uterine tissues during pregnancy. Early adaptations may enhance function, but persistent stress eventually causes tissue damage.Types of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Combination Therapy with Bisoprolol and Tissue Protective Molecule ARA 284 Is Cardio-Protective and Improves Survival in Experimental Cancer Cachexia.

Journal of cardiovascular development and disease·2026
Same author

Combined Bisoprolol and Megestrol Acetate Improves Survival and Preserves Cardiac Performance in a Rat Model of Cancer Cachexia.

Journal of cachexia, sarcopenia and muscle·2026
Same author

Combined Nutritional and Exercise Interventions for Cachexia in Chronic Diseases: A Systematic Review and Meta-analysis Limited to Cancer Cachexia.

Progress in rehabilitation medicine·2026
Same author

New models for cancer cachexia and their application to drug discovery.

Expert opinion on drug discovery·2025
Same author

Intermittent Hypoxic-Hyperoxic Training During Inpatient Rehabilitation Improves Exercise Capacity and Functional Outcome in Patients With Long Covid: Results of a Controlled Clinical Pilot Trial.

Journal of cachexia, sarcopenia and muscle·2024
Same author

Effects of S-pindolol in mouse pancreatic and lung cancer cachexia models.

Journal of cachexia, sarcopenia and muscle·2023

Related Experiment Video

Updated: May 20, 2026

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
08:55

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

Published on: November 30, 2016

The underestimated impact of cachexia.

Jochen Springer1, Stefan D Anker

  • 1Applied Cachexia Research, Charité Medical School, Berlin, Germany.

Expert Opinion on Drug Discovery
|July 25, 2012
PubMed
Summary
This summary is machine-generated.

Animal research is crucial for understanding cachexia, a debilitating syndrome impacting patients with chronic diseases. Designing pre-clinical studies with clinical trial relevance is essential for developing effective cachexia therapies.

Related Experiment Videos

Last Updated: May 20, 2026

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
08:55

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

Published on: November 30, 2016

Area of Science:

  • Biomedical Research
  • Translational Medicine
  • Disease Pathophysiology

Background:

  • Cachexia is a severe wasting syndrome linked to chronic diseases, significantly reducing patient quality of life and survival.
  • This syndrome is often underdiagnosed and undertreated, with limited therapeutic options currently available.
  • The lack of effective treatments highlights the urgent need for robust research into cachexia's mechanisms and potential interventions.

Purpose of the Study:

  • To emphasize the critical role of animal research in advancing the understanding and treatment of cachexia.
  • To advocate for improved design in pre-clinical cachexia studies.
  • To propose that animal model studies should more closely mimic clinical trials, focusing on clinically relevant endpoints.

Main Methods:

  • This editorial discusses the importance and strategic design of animal research for cachexia.
  • It proposes a framework for pre-clinical studies that aligns with clinical trial methodologies.
  • The focus is on utilizing primary endpoints that have direct clinical relevance for patient outcomes.

Main Results:

  • Animal models are indispensable for investigating the complex pathophysiology of cachexia.
  • Careful study design in animal research is necessary to ensure translatability to human conditions.
  • Implementing clinically relevant endpoints in pre-clinical studies can accelerate the development of effective cachexia therapies.

Conclusions:

  • Further research, particularly in well-designed animal models, is vital for tackling cachexia.
  • Adopting a clinical trial-like approach in pre-clinical research will enhance the development of successful therapies.
  • Improving the identification, diagnosis, and treatment of cachexia through dedicated research is a priority.